On November 28, 2016, the 21th participant out of 23 completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado, led by Principal Investigator Marcela Ot’alora, M.A., L.P.C. These data will provide additional information to guide the design of our upcoming Phase 3 trials. The final results are being prepared for publication, which is expected in 2017. Learn more…